Home/Hedge Fund Intelligence/Acadia Pharmaceuticals Inc
Nasdaq: ACADStockForm 13F30 Jun 2026

Hedge funds that hold Acadia Pharmaceuticals Inc Nasdaq: ACAD

CUSIP 004225108 · who reports it, how much, and how much it matters to them

32 of the 720 hedge fund managers we track reported shares of Acadia Pharmaceuticals Inc (Nasdaq: ACAD) on Form 13F for 30 June 2026. Between them they reported USD 1.8bn. The largest position belongs to Baker Bros. Advisors, at USD 1.1bn. The manager with the most riding on it is Palo Alto Investors, where it is 10.0% of the reported book.

Managers reporting it32of 720 we track
Value they reportUSD 1.8bnshares only, 30 Jun 2026
Funds they run413with a file on PPLI.com
Largest positionUSD 1.1bnBaker Bros. Advisors
Typical weight0.0%median share of a manager's book
Heaviest weight10.0%Palo Alto Investors

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

32 managers, USD 1.8bn between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports Acadia Pharmaceuticals Inc, largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Baker Bros. Advisors2 funds on PPLI.comUSD 1.1bn5.4%
2RTW Investments2 funds on PPLI.comUSD 181m1.5%
3Palo Alto Investors6 funds on PPLI.comUSD 72m10.0%
4POINT72 Asset Management17 funds on PPLI.comUSD 62m0.1%
5Citadel Advisors32 funds on PPLI.comUSD 55m0.0%
6Marshall Wace LLP84 funds on PPLI.comUSD 45m0.0%
7D. E. Shaw & Co.15 funds on PPLI.comUSD 43m0.0%
8Braidwell12 funds on PPLI.comUSD 42m1.5%
9Artisan Partners1 fund on PPLI.comUSD 34m0.1%
10Renaissance Technologies13 funds on PPLI.comUSD 32m0.0%
11Two Sigma Investments35 funds on PPLI.comUSD 23m0.0%
12Millennium Management6 funds on PPLI.comUSD 15m0.0%
13Adage Capital Management1 fund on PPLI.comUSD 13m0.0%
14Hudson Bay Capital Management8 funds on PPLI.comUSD 12m0.0%
15Balyasny Asset Management25 funds on PPLI.comUSD 9.8m0.0%
16Sphera Funds Management1 fund on PPLI.comUSD 9m1.2%
17Schonfeld Strategic Advisors30 funds on PPLI.comUSD 7.2m0.0%
18Edgestream Partners5 funds on PPLI.comUSD 7.2m0.2%
19Logos Global Management1 fund on PPLI.comUSD 6.3m0.3%
20Squarepoint Ops7 funds on PPLI.comUSD 3.5m0.0%
21Orbimed Advisors1 fund on PPLI.comUSD 3.5m0.1%
22Campbell & Company Investment Adviser8 funds on PPLI.comUSD 2.1m0.1%
23Verdad Advisers6 funds on PPLI.comUSD 2.1m2.0%
24Freestone Grove Partners1 fund on PPLI.comUSD 1.8m0.0%
25Bridgewater Associates45 funds on PPLI.comUSD 1.3m0.0%
26The Quarry1 fund on PPLI.comUSD 1.3m0.1%
27Capstone Investment Advisors25 funds on PPLI.comUSD 467,0000.0%
28Boothbay Fund Management2 funds on PPLI.comUSD 435,0000.0%
29Entrypoint Capital1 fund on PPLI.comUSD 324,0000.1%
30Diametric Capital2 funds on PPLI.comUSD 308,0000.0%
31Graticule Asia Macro Advisors8 funds on PPLI.comUSD 22,4920.0%
32Persistent Asset Partners10 funds on PPLI.comUSD 18,0900.0%
Next: where it matters most
Where it matters most

For Palo Alto Investors it is 10.0% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Palo Alto InvestorsUSD 72m10.0%
2Baker Bros. AdvisorsUSD 1.1bn5.4%
3Verdad AdvisersUSD 2.1m2.0%
4RTW InvestmentsUSD 181m1.5%
5BraidwellUSD 42m1.5%
6Sphera Funds ManagementUSD 9m1.2%
7Logos Global ManagementUSD 6.3m0.3%
8Edgestream PartnersUSD 7.2m0.2%
9Campbell & Company Investment AdviserUSD 2.1m0.1%
10The QuarryUSD 1.3m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds Acadia Pharmaceuticals Inc

What is the ticker symbol of Acadia Pharmaceuticals Inc?

Acadia Pharmaceuticals Inc trades under the symbol ACAD on the Nasdaq. Its CUSIP, the code used on Form 13F, is 004225108.

Which hedge funds own Acadia Pharmaceuticals Inc (Nasdaq: ACAD)?

32 of the 720 hedge fund managers PPLI.com tracks reported Acadia Pharmaceuticals Inc shares on Form 13F for 30 June 2026. The largest reported positions were held by Baker Bros. Advisors (USD 1.1bn), RTW Investments (USD 181m), Palo Alto Investors (USD 72m), POINT72 Asset Management (USD 62m) and Citadel Advisors (USD 55m).

How many hedge funds hold Acadia Pharmaceuticals Inc?

32 managers in our coverage reported it, and between them they run 413 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on Acadia Pharmaceuticals Inc?

Palo Alto Investors, where the position was 10.0% of the reported 13F book at 30 June 2026.

Does this show who is short Acadia Pharmaceuticals Inc?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with Acadia Pharmaceuticals Inc or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.